Latest from Optum Life Sciences
Clinicogenomics: New data advances life sciences research
The study of clinicogenomics is helping researchers unlock novel insights to guide drug discovery, development and commercialization.
Hear how Optum supported the FDA by analyzing COVID-19 vaccine safety.
Evidence in Action newsletter
Sign up to receive Optum Life Sciences expert perspectives and industry news delivered to your inbox quarterly.
Cross-industry conversations featuring Optum experts
Inside the science of genetics and genomics by STAT
Explore the evolving research into human genetics and genomics, the promise of gene therapies, and the questions faced in the years ahead.
The evolving market for real-world evidence
Experts from Optum Life Sciences and Advisory Board Research share four bold predictions regarding the future use of real-world data.
RWE is critical to the whole health care ecosystem
Lou Brooks, SVP of Real-World Data and Analytics, joins the Radio Advisory podcast to talk about the evolving world of clinical evidence.